Suppr超能文献

实施抗菌药物管理计划对优化革兰氏阴性杆菌菌血症抗生素治疗的影响。

Impact of Implementing an Antimicrobial Stewardship Program for Optimizing Antibiotic Treatment in Gram-negative Bacilli Bacteremia.

作者信息

García-Cervera Carles, Jover-Díaz Francisco Mariano, Delgado-Sánchez Elisabet, Martin-González Coral, Provencio-Arranz Rosa, Infante-Urrios Ana, Dólera-Moreno Cristina, Esteve-Atiénzar Pedro, Lazcano Teresa Martínez, Peris-García Jorge, Giner-Galvañ Vicente, Ducasse Victoria Ortiz de la Tabla, Sánchez-Miralles Ángel, Aznar-Saliente Teresa

机构信息

Internal Medicine Service, Hospital Clínico Universitario de San Juan de Alicante, Alicante, Spain.

Infectious Diseases Unit, Hospital Clínico Universitario de San Juan de Alicante, Alicante, Spain.

出版信息

Infect Chemother. 2024 Sep;56(3):351-360. doi: 10.3947/ic.2024.0026. Epub 2024 Jul 4.

Abstract

BACKGROUND

Antibiotic Stewardship Programs (ASP) have improved empirical and directed antibiotic treatment in Gram-negative Bacilli (GNB) bloodstream infections. A decrease in mortality, readmission, and length of hospitalization has been reported.

MATERIALS AND METHODS

A pre-post-quasi-experimental study was conducted between November and April 2015-2016 (pre-intervention period), 2016-2017, 2017-2018, and 2018-2019 (post-intervention periods), to analyse the impact of ASP on empirical, directed, and entire treatment optimization, as well as mortality, readmission, and length of hospitalization, in hospitalized patients with Gram-negative bacilli (GNB) bloodstream infections.

RESULTS

One hundred seventy-four patients were included (41 in the pre-intervention group, 38 in the first-year post-intervention group, 50 in the second-year post-intervention group, and 45 in the third-year post-intervention group). There was a significant improvement in directed treatment optimization (43.9% in the pre-intervention group, 68.4% in the first-year post-intervention group, 74% in the second-year post-intervention group, and 88.9% in the third-year post-intervention group, <0.001), as well as in entire treatment optimization (19.5%, 34.2%, 40.0%, and 46.7%, respectively, =0.013), with increased optimal directed (adjusted odds ratio [aOR], 3.71; 95% confidence interval [CI], 1.60-8.58) and entire treatment (aOR, 3.31; 95% CI, 1.27-8.58). Although a tendency toward improvement was observed in empirical treatment after ASP implementation, it did not reach statistical significance (41.5% 57.9%, =0.065). No changes in mortality, readmission, or length of hospitalization were detected.

CONCLUSION

ASP implementation improved both directed and entire treatment optimization in patients with GNB bloodstream infections over time. Nevertheless, no improvement was found in clinical outcomes such as mortality, readmission, or length of hospitalization.

摘要

背景

抗生素管理计划(ASP)已改善了革兰氏阴性杆菌(GNB)血流感染的经验性和针对性抗生素治疗。据报道,死亡率、再入院率和住院时间有所下降。

材料与方法

在2015 - 2016年11月至4月(干预前期)、2016 - 2017年、2017 - 2018年和2018 - 2019年(干预后期)进行了一项前后对照的准实验研究,以分析ASP对革兰氏阴性杆菌(GNB)血流感染住院患者的经验性、针对性和整体治疗优化以及死亡率、再入院率和住院时间的影响。

结果

共纳入174例患者(干预前期组41例,干预后第一年组38例,干预后第二年组50例,干预后第三年组45例)。针对性治疗优化有显著改善(干预前期组为43.9%,干预后第一年组为68.4%,干预后第二年组为74%,干预后第三年组为88.9%,<0.001),整体治疗优化也有改善(分别为19.5%、34.2%、40.0%和46.7%,P = 0.013),最佳针对性治疗(调整优势比[aOR],3.71;95%置信区间[CI],1.60 - 8.58)和整体治疗(aOR,3.31;95% CI,1.27 - 8.58)均增加。尽管在实施ASP后经验性治疗有改善趋势,但未达到统计学显著性(41.5%对57.9%,P = 0.065)。未检测到死亡率、再入院率或住院时间的变化。

结论

随着时间的推移,实施ASP改善了GNB血流感染患者的针对性和整体治疗优化。然而,在死亡率、再入院率或住院时间等临床结局方面未发现改善。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验